In a new study, North Carolina State University researchers characterize a range of molecular tools to rewrite – not just edit – large chunks of an organism’s DNA, based on CRISPR-Cas systems associated with selfish genetic “hitchhikers” called transposons.
Read More
In what is believed to be a first, a research team led by Duke Health has demonstrated a way to use CRISPR technology to successfully prevent and treat COVID infections.
Read More
Earlier this year, WRAL published a series titled Innovation Road Trip that featured six video and story packages from across North Carolina. Check out part one.
Read More
U.S. regulators have cleared the way for the sale of beef from gene-edited cattle in coming years after the Food and Drug Administration concluded the animals do not raise any safety concerns.
Read More
Pairwise – which uses its CRISPR-Cas9 gene editing know-how to develop new varieties of fruits and vegetables – has agreed to grant access to its base editing technology to U.K.-headquartered Tropic Biosciences. Here’s what’s happening,
Read More
With the ability to replace and modify genes, CRISPR technology has the potential to solve some of the world’s biggest problems.
Read More
WRAL TechWire spoke with the cofounder and CEO of Locus Biosciences, Paul Garofolo, about the company’s expansion and location in the Research Triangle Park, and about the current state of the life science and biopharmaceutical industries.
Read More
A new facility at the University of North Carolina at Chapel Hill will enable researchers to screen for new drug targets using CRISPR, the powerful genome-editing technology that is accelerating discovery and development across the life sciences.
Read More
IngateyGen has been awarded a $1 million SBIR grant by the National Science Foundation to develop technology that could remove allergens from peanuts.
Read More
